VTmarooncmykinvt   completed research text box

Rafael DavalosDavalos  RCGM PictureInvestigator: Dr. Rafael Davalos (Virginia Tech)

Co-investigator: Dr. Robert C.G. Martin, II (University of Louisville)

Disease: Pancreatic Cancer

Research Description: Irreversible electroporation (IRE) is a non-thermal, focused procedure that relies on the delivery of short, yet intense, electrical pulses to destroy the target tissue. These pulses damage the cell membrane, which in turn kills the cells. IRE is ideally suited to treat patients with tumors that cannot be removed via surgery (unresectable), because it destroys the tumor without damaging the surrounding tissue. The use of IRE has been shown to dramatically improve the lifespan of thousands of patients suffering from unresectable prostate, liver, pancreatic and adrenal cancers. This clinical project will use an IRE device to treat pancreatic cancer patients and will track the immune response to this IRE treatment. The IRE treatment will be optimized to increase the immune response in patients, which then could be used to help fight the cancer. Results from this study will be used to effectively combine IRE with immunotherapy in subsequent studies, with the hope of improving patient outcomes in pancreatic cancer.

CWR funding role: Primary funder

Completed: 2018

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*

*required

If the link above doesn't work, please contact our Admin support at admin@cureswithinreach.org with your Full Name and Email Address to sign up!

 

Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Monday the 16th. Copyright 2018 Cures Within Reach.